rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2011-4-18
|
pubmed:abstractText |
The present study examined the inhibitory action of temporary treatment with an angiotensin type 1 (AT(1)) receptor blocker (ARB) on vascular remodeling using hypertensive mice with overexpression of the human renin (hRN) and angiotensinogen (hANG) genes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1941-7225
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
550-6
|
pubmed:meshHeading |
pubmed-meshheading:21293390-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:21293390-Angiotensinogen,
pubmed-meshheading:21293390-Animals,
pubmed-meshheading:21293390-Arteries,
pubmed-meshheading:21293390-Blood Vessels,
pubmed-meshheading:21293390-Disease Models, Animal,
pubmed-meshheading:21293390-Hydralazine,
pubmed-meshheading:21293390-Hypertension,
pubmed-meshheading:21293390-Mice,
pubmed-meshheading:21293390-Mice, Inbred C57BL,
pubmed-meshheading:21293390-NADPH Oxidase,
pubmed-meshheading:21293390-Neointima,
pubmed-meshheading:21293390-Oxidative Stress,
pubmed-meshheading:21293390-Renin,
pubmed-meshheading:21293390-Tetrazoles,
pubmed-meshheading:21293390-Valine
|
pubmed:year |
2011
|
pubmed:articleTitle |
Temporary treatment with AT1 receptor blocker, valsartan, from early stage of hypertension prevented vascular remodeling.
|
pubmed:affiliation |
Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|